Cracking the China conundrum & "Robo-reps"
This article was originally published in Scrip
Think China, think Europe and deploy a mix of traditional and new digital channels to drive growth in the world's second-largest healthcare market. And yes, tele-video detailing/remote detailing, or a "Robo-rep" approach if you will, hold significant scope in China to provide an effective method to reach healthcare professionals directly, with a clear high return on investment.
You may also be interested in...
Ransomware Attacks: The State Of Play As Indian Firms Mount Defense
Pharma continues to be targeted by cyber criminals – the latest being India’s top-ranked company, Sun Pharma. Experts highlight some of the key vulnerabilities and why firms need to prioritize cyber resilience.
What Pharma CEOs, PEs Want To Move The Innovation Needle In India
Leaders of biopharma and private equity firms at a recent conference sought a robust domestic market and reimbursement mechanism to propel the innovation ecosystem in India, drawing parallels with the framework that aided China's ascent in the R&D value chain. Alongside, regulatory reform is also pivotal, they stressed.
Backed By Big Names, Etherna Hopes To Disrupt mRNA Space
Belgian mRNA technologies firm Etherna, which is backed by high profile investors including former Bayer CEO Marijn Dekkers and Moderna co-founder Kenneth Chien, has reoriented its business model. Interim CEO Bernard Sagaert tells In Vivo how the firm hopes to deliver superior products for partners in the rapidly expanding RNA space.